PWG
STIM icon

Portside Wealth Group’s Neuronetics STIM Stock Holding History

Portside Wealth Group’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,815
Closed -$36.2K – 382
2023
Q2 		$36.2K Buy
+16,815
New +$40.8K 0.01% 362

Other funds holding STIM

ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Portside Wealth Group's STIM Position: Q3 2023 in Review

Portside Wealth Group sold out of Neuronetics (STIM) in Q3 2023, closing a stake of 16,815 shares — an estimated $36.2K sold.

Portside Wealth Group first reported a position in STIM in Q2 2023 and held it in 1 quarter. The position peaked at $36.2K in Q2 2023. 56 funds tracked by Wall St. Rank hold STIM as of Q3 2023.

  • Portside Wealth Group reported no remaining Neuronetics position as of Q3 2023 after selling out during the quarter.
  • Portside Wealth Group sold 16,815 Neuronetics shares in Q3 2023, an estimated $36.2K.
  • Portside Wealth Group first reported a position in Neuronetics in Q2 2023 and held it in 1 quarter.
  • Portside Wealth Group's Neuronetics position peaked at $36.2K in Q2 2023.
  • 56 funds tracked by Wall St. Rank held Neuronetics as of Q3 2023.

Based on Portside Wealth Group's 13F filing for Q3 2023, filed 27 Oct 2023.